Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Koskela-Niska V et al. Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study. 2013 Climacteric pmid:22640598
Brosnan JF et al. Norethisterone acetate alters coagulation gene expression in vitro in human cell culture. 2013 Thromb. Res. pmid:22999413
Archer DF et al. Norethindrone acetate 1.0 milligram and ethinyl estradiol 10 micrograms as an ultra low-dose oral contraceptive. 2013 Obstet Gynecol pmid:23921878
Gutsche JT et al. Treatment of ventricular assist-device-associated gastrointestinal bleeding with hormonal therapy. 2013 J. Cardiothorac. Vasc. Anesth. pmid:24054188
Wistuba J et al. Experimental endocrine manipulation by contraceptive regimen in the male marmoset (Callithrix jacchus). 2013 Reproduction pmid:23431271
Tomasicchio M et al. The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor. 2013 PLoS ONE pmid:23658782
Polisseni AF et al. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study. 2013 Maturitas pmid:23201326
Schneck H et al. Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells. 2013 Gynecol. Endocrinol. pmid:23116217
Połać I et al. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration. 2013 Gynecol. Endocrinol. pmid:23116237
Chen FP et al. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors. 2013 Taiwan J Obstet Gynecol pmid:24075375
Minami T et al. Antiproliferative and apoptotic effects of norethisterone on endometriotic stromal cells in vitro. 2013 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:22964137
Crean CS et al. The effect of ezogabine on the pharmacokinetics of an oral contraceptive agent. 2013 Int J Clin Pharmacol Ther pmid:24040852
Price T Progesterone receptor membrane component 1: is metabolism integral to its function and what other steroids are involved? 2013 Menopause pmid:23511707
Stanczyk FZ and Winer SA Effect of hormone therapy on breast epithelial cell proliferation. 2013 Menopause pmid:23615638
Cheng G et al. Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women. 2013 Menopause pmid:23615640
Demeestere I et al. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. 2013 J. Clin. Oncol. pmid:23129737
Vercellini P et al. Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: effect on sexual functioning, psychological status and health-related quality of life. 2013 Hum. Reprod. pmid:23442755
Africander D et al. Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy. 2013 Biochem. Biophys. Res. Commun. pmid:23473756
Ralph LJ et al. Next steps for research on hormonal contraception and HIV. 2013 Lancet pmid:23810224
Zhou J et al. Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. 2013 Maturitas pmid:23856385
Roach RE et al. The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy. 2013 J. Thromb. Haemost. pmid:23136837
Juvkam KH and Gudim HB [Drug induced displacement of menstruation]. 2013 Tidsskr. Nor. Laegeforen. pmid:23344601
Buccellato E et al. Possible occurrence of paraesthesia in patients taking norethisterone: an analysis on the WHO Global Individual Case Reports database (VigiBase). 2013 Expert Opin Drug Saf pmid:23701188
Manassiev N et al. Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism. 2013 Clin. Endocrinol. (Oxf) pmid:22775481
Merviel P et al. [Interest of selective progesterone receptor modulators in endometriosis]. 2013 Gynecol Obstet Fertil pmid:23972920
Abdul-Hadi RA et al. The effectiveness of community based distribution of injectable contraceptives using community health extension workers in Gombe State, Northern Nigeria. 2013 Afr J Reprod Health pmid:24069754
Fels H et al. Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives. 2013 Contraception pmid:23352800
Polis CB and Curtis KM Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. 2013 Lancet Infect Dis pmid:23871397
Biddle ST et al. Metabolism of norethisterone in the greyhound. 2013 Rapid Commun. Mass Spectrom. pmid:24019188
Ferrero S et al. Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies. 2013 Arch. Gynecol. Obstet. pmid:23053314
Mackay L et al. Hormone replacement therapy for women with type 1 diabetes mellitus. 2013 Cochrane Database Syst Rev pmid:23744560
LoRusso PM et al. Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential. 2013 Cancer Chemother. Pharmacol. pmid:23064958
Jonusiene G et al. Sexual function, mood and menopause symptoms in Lithuanian postmenopausal women. 2013 Climacteric pmid:22845491
Adeyemi AS and Adekanle DA Progestogen-only injectable contraceptive: experience of women in Osogbo, southwestern Nigeria. 2012 Jan-Mar Ann Afr Med pmid:22199044
Naqaish T et al. Patient satisfaction for levonorgestrel intrauterine system and norethisterone for treatment of dysfunctional uterine bleeding. 2012 Jan-Mar J Ayub Med Coll Abbottabad pmid:23855088
Arowojolu AO et al. Combined oral contraceptive pills for treatment of acne. 2012 Cochrane Database Syst Rev pmid:22786490
Rott H Thrombotic risks of oral contraceptives. 2012 Curr. Opin. Obstet. Gynecol. pmid:22729096
Cobia DJ et al. Longitudinal progression of frontal and temporal lobe changes in schizophrenia. 2012 Schizophr. Res. pmid:22647883
Ruan X et al. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells. 2012 Climacteric pmid:22335423
Espey E et al. Effect of progestin compared with combined oral contraceptive pills on lactation: a randomized controlled trial. 2012 Obstet Gynecol pmid:22143258
Vercellini P et al. Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction. 2012 Hum. Reprod. pmid:22926841
Morrison CS et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa. 2012 AIDS pmid:22156973
Garg V et al. The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir. 2012 J Clin Pharmacol pmid:22039291
Chawla B et al. A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani. 2012 PLoS ONE pmid:22438895
Muneyyirci-Delale O et al. Medical management of recurrent endometrioma with long-term norethindrone acetate. 2012 Int J Womens Health pmid:22505834
Castilho CS et al. Genetic structure and conservation of Mountain Lions in the South-Brazilian Atlantic Rain Forest. 2012 Genet. Mol. Biol. pmid:22481876
Kumar V et al. Bioremediation of agro-based pulp mill effluent by microbial consortium comprising autochthonous bacteria. 2012 ScientificWorldJournal pmid:22448126
Gümüş BA and Neubert E New taxa of terrestrial molluscs from Turkey (Gastropoda, Pristilomatidae, Enidae, Hygromiidae, Helicidae). 2012 Zookeys pmid:22423194
Malherbe CJ et al. Development of on-line high performance liquid chromatography (HPLC)-biochemical detection methods as tools in the identification of bioactives. 2012 Int J Mol Sci pmid:22489144
Puli MR and Raghavendra AS Pyrabactin, an ABA agonist, induced stomatal closure and changes in signalling components of guard cells in abaxial epidermis of Pisum sativum. 2012 J. Exp. Bot. pmid:22131162